Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ensysce Biosciences Inc
(NQ:
ENSC
)
0.4300
-0.1624 (-27.41%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ensysce Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Ensysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical Edge Magazine
April 25, 2024
Via
ACCESSWIRE
Ensysce Biosciences' Presentation from the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference Published
April 19, 2024
Via
ACCESSWIRE
Ensysce Biosciences to Participate in the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
April 09, 2024
Via
ACCESSWIRE
FSR Stock: The $150 Million Reason Fisker Shares Are Moving Today
March 18, 2024
Fisker stock is on the move Monday as FSR investors learn about the EV company securing an additional $150 million in funding.
Via
InvestorPlace
ENSC Stock Earnings: Ensysce Biosciences Misses EPS, Beats Revenue for Q4 2023
March 18, 2024
ENSC stock results show that Ensysce Biosciences missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results
March 15, 2024
Via
ACCESSWIRE
Ensysce Biosciences Announces Successful Meeting with FDA for PF614-MPAR, a Next Generation Opioid with Overdose Protection
February 21, 2024
Via
ACCESSWIRE
Ensysce Biosciences Announces Publication of Clinical Bioequivalence Manuscript
February 15, 2024
Via
ACCESSWIRE
Ensysce Biosciences Selected to Present at American Association of Pain Medicine Annual Conference
February 06, 2024
Via
ACCESSWIRE
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
February 27, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 13, 2024
Via
Benzinga
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $4.7 Million Gross Proceeds
February 13, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 31, 2024
Via
Benzinga
Ensysce Biosciences Announces Positive End of Phase 2 Meeting with FDA for PF614 to Treat Severe Pain
January 31, 2024
Via
ACCESSWIRE
Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR
January 23, 2024
Via
ACCESSWIRE
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 31, 2024
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on...
Via
Benzinga
Ensysce Biosciences to Present Groundbreaking Oral Overdose Protection for Opioids at the 5th Annual NIH HEAL Meeting
January 25, 2024
Via
ACCESSWIRE
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 24, 2024
Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 24, 2024
Via
Benzinga
Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
January 24, 2024
Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-expected sal
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
Crude Oil Down 1%; Lockheed Martin Earnings Top Views
January 23, 2024
U.S. stocks traded mixed toward the end trading, with the Dow Jones index falling around 100 points on Tuesday. The Dow traded down 0.26% to 37,903.57 while the NASDAQ rose 0.25% to 15,399.02. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Opioid Developer Ensysce Biosciences Stock Is Shooting Higher Today - Here's Why
January 23, 2024
Ensysce Biosciences breakthrough in opioid innovation! FDA grants PF614-MPAR BTD for enhanced pain relief with overdose protection. Learn more about this cutting-edge drug.
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 23, 2024
Via
Benzinga
Dow Tumbles 150 Points; Procter & Gamble Shares Rise On Upbeat Earnings
January 23, 2024
U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.43% to 37,837.65 while the NASDAQ fell 0.01% to 15,358.79. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 23, 2024
Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 15, 2024
Via
Benzinga
Ensysce Biosciences Issues 2024 Shareholder Letter
January 08, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
December 21, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.